Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK.

El Bouzidi K, White E, Mbisa JL, Phillips A, Mackie N, Pozniak A, Dunn D.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19739. doi: 10.7448/IAS.17.4.19739. eCollection 2014.

PMID:
25397484
[PubMed - in process]
Free PMC Article
2.

Service impact of a change in HIV-1 viral load quantification assay.

Tipple C, Oomeer S, Dosekun O, Mackie N.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19677. doi: 10.7448/IAS.17.4.19677. eCollection 2014.

PMID:
25397427
[PubMed - in process]
Free PMC Article
3.

End-stage kidney disease and kidney transplantation in HIV-positive patients: an observational cohort study.

Gathogo E, Jose S, Jones R, Levy JB, Mackie NE, Booth J, Connolly J, Johnson M, Leen C, Williams D, Sabin CA, Post FA.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):177-80. doi: 10.1097/QAI.0000000000000291.

PMID:
25072607
[PubMed - in process]
4.

Rilpivirine exposure in plasma and sanctuary site compartments after switching from nevirapine-containing combined antiretroviral therapy.

Mora-Peris B, Watson V, Vera JH, Weston R, Waldman AD, Kaye S, Khoo S, Mackie NE, Back D, Winston A.

J Antimicrob Chemother. 2014 Jun;69(6):1642-7. doi: 10.1093/jac/dku018. Epub 2014 Feb 11.

PMID:
24521854
[PubMed - in process]
5.

The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adults.

Mackie NE, Dunn DT, Dolling D, Garvey L, Harrison L, Fearnhill E, Tilston P, Sabin C, Geretti AM; UK HIV Drug Resistance Database; UK CHIC study.

AIDS. 2013 Sep 10;27(14):2245-53. doi: 10.1097/QAD.0b013e3283636179.

PMID:
24157905
[PubMed - indexed for MEDLINE]
6.

The safety of flucloxacillin in HIV-infected patients with positive HLA-B*5701 genotype.

Vera JH, Naous N, Mackie N, Winston A, Cooke G.

AIDS. 2013 Jan 28;27(3):484-5. doi: 10.1097/QAD.0b013e32835a9a0d.

PMID:
23032409
[PubMed - indexed for MEDLINE]
7.

Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study.

UK Collaborative Group on HIV Drug Resistance, Dolling D, Sabin C, Delpech V, Smit E, Pozniak A, Asboe D, Brown AL, Churchill D, Williams I, Geretti AM, Phillips A, Mackie N, Murphy G, Castro H, Pillay D, Cane P, Dunn D, Dolling D.

BMJ. 2012 Aug 21;345:e5253. doi: 10.1136/bmj.e5253.

PMID:
22915687
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Factors associated with cerebrospinal fluid HIV RNA in HIV infected subjects undergoing lumbar puncture examination in a clinical setting.

Rawson T, Muir D, Mackie NE, Garvey LJ, Everitt A, Winston A.

J Infect. 2012 Sep;65(3):239-45. doi: 10.1016/j.jinf.2012.04.007. Epub 2012 Apr 17.

PMID:
22522289
[PubMed - indexed for MEDLINE]
9.

Hemodiafiltration with online regeneration of ultrafiltrate for severe nevirapine intoxication in a HIV-infected patient.

Hougardy JM, Husson C, Mackie NE, Van Vooren JP, Gastaldello K, Nortier JL, Goffard JC.

AIDS. 2012 Mar 13;26(5):653-5. doi: 10.1097/QAD.0b013e3283509770. No abstract available.

PMID:
22398572
[PubMed - indexed for MEDLINE]
10.

Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection.

Hamlyn E, Hickling S, Porter K, Frater J, Phillips R, Robinson M, Mackie NE, Kaye S, McClure M, Fidler S; SPARTAC Investigators.

AIDS. 2012 Apr 24;26(7):887-90. doi: 10.1097/QAD.0b013e328351e721.

PMID:
22313951
[PubMed - indexed for MEDLINE]
11.

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.

Prosperi MC, Mackie N, Di Giambenedetto S, Zazzi M, Camacho R, Fanti I, Torti C, Sönnerborg A, Kaiser R, Codoñer FM, Van Laethem K, Bansi L, van de Vijver DA, Geretti AM, De Luca A; SEHERE consortium.

J Antimicrob Chemother. 2011 Aug;66(8):1886-96. doi: 10.1093/jac/dkr171. Epub 2011 May 30.

PMID:
21624929
[PubMed - indexed for MEDLINE]
Free Article
12.

The impact of HIV drug resistance testing on changes to treatment.

Bansi L, Smith C, Phillips A, Kirk S, Geretti AM, Johnson M, Mackie N, Post F, Gazzard B, Dunn D, Sabin C; UK Collaborative HIV Cohort (CHIC) Study and the UK Collaborative Group on HIV Drug Resistance (HDRD).

AIDS. 2011 Mar 13;25(5):603-10. doi: 10.1097/QAD.0b013e32834403a0.

PMID:
21297420
[PubMed - indexed for MEDLINE]
13.

Resistance to non-nucleoside reverse transcriptase inhibitors.

Mackie N.

In: Geretti AM, editor. Antiretroviral Resistance in Clinical Practice. London: Mediscript; 2006. Chapter 2.

14.

Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment.

Vandekerckhove L, Verhofstede C, Demecheleer E, De Wit S, Florence E, Fransen K, Moutschen M, Mostmans W, Kabeya K, Mackie N, Plum J, Vaira D, Van Baelen K, Vandenbroucke I, Van Eygen V, Van Marck H, Vogelaers D, Geretti AM, Stuyver LJ.

J Antimicrob Chemother. 2011 Feb;66(2):265-72. doi: 10.1093/jac/dkq458. Epub 2010 Dec 31.

PMID:
21196489
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine.

Waters L, Fisher M, Winston A, Higgs C, Hadley W, Garvey L, Mandalia S, Perry N, Nicola M, Nelson M.

AIDS. 2011 Jan 2;25(1):65-71. doi: 10.1097/QAD.0b013e328341685b.

PMID:
21099666
[PubMed - indexed for MEDLINE]
16.

The effects of a nucleoside-sparing antiretroviral regimen on the pharmacokinetics of ritonavir-boosted darunavir in HIV type-1-infected patients.

Garvey L, Latch N, Erlwein OW, Mackie NE, Walsh J, Scullard G, McClure MO, Dickinson L, Back D, Winston A.

Antivir Ther. 2010;15(2):213-8. doi: 10.3851/IMP1517.

PMID:
20386076
[PubMed - indexed for MEDLINE]
17.

Antiretroviral drug resistance in HIV-1-infected patients with low-level viremia.

Mackie NE, Phillips AN, Kaye S, Booth C, Geretti AM.

J Infect Dis. 2010 May 1;201(9):1303-7. doi: 10.1086/651618.

PMID:
20350161
[PubMed - indexed for MEDLINE]
Free Article
18.

Clinical epidemiology of HIV-associated end-stage renal failure in the UK.

Bansi L, Hughes A, Bhagani S, Mackie NE, Leen C, Levy J, Edwards S, Connolly J, Holt SG, Hendry BM, Sabin C, Post FA; UK CHIC/ESRF study group.

AIDS. 2009 Nov 27;23(18):2517-21. doi: 10.1097/QAD.0b013e3283320e12.

PMID:
19752713
[PubMed - indexed for MEDLINE]
19.

Detectable cerebrospinal fluid HIV RNA with associated neurological deficits, despite suppression of HIV replication in the plasma compartment.

Garvey LJ, Everitt A, Winston A, Mackie NE, Benzie A.

AIDS. 2009 Jul 17;23(11):1443-4. doi: 10.1097/QAD.0b013e32832d077c. No abstract available.

PMID:
19564723
[PubMed - indexed for MEDLINE]
20.

High treatment success rates when switching to once daily nevirapine containing antiretroviral therapy.

Benzie A, Marett B, Mackie NE, Winston A.

Open AIDS J. 2008;2:89-93. doi: 10.2174/1874613600802010089. Epub 2008 Dec 18.

PMID:
19274065
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk